Skip to Content

Xifaxan Salix Pharmaceuticals, Ltd - Treatment for Travelers’ Diarrhea

Xifaxan is a nonsystemic gastrointestinal-selective, oral antibiotic indicated for the treatment of patients (12 years of age and older) with traveler's diarrhea caused by noninvasive strains of Escherichia coli.

Posted: May 2004

Related Articles:

Xifaxan (rifaximin) FDA Approval History

View comments